InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,509.01
(
0.62%
)
US TECH 100
19,460.00
(
0.95%
)
Dow Jones
39,331.85
(
0.41%
)
Brent Oil
86.28
(
-0.19%
)
Bitcoin
62,160.21
(
0.21%
)
Post# of 252466
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

kris_kade

Send PM Follow Ignore
Followers 22
Posts 1671
Boards Moderated 0
Alias Born 12/12/2006

kris_kade

Re: researcher59 post# 156822

Monday, 02/11/2013 10:28:07 PM

Monday, February 11, 2013 10:28:07 PM

Post# of 252466
Agree..the institutions paid $25+ and they were oversubscribed ! SRPT is unlikely to go any lower than low 20's. A likely scenario is FDA may ask SRPT to do a controlled but short trial (aka expanded PI) in line with their new paradigm shift of supporting pathways for innovative drugs. Eteplirsen definitely qualifies in that regard.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up